Kangmei Pharma | 600518 - Aktuelle Verpflichtungen

Aktienkurs
1.79
Täglich Wechseln
-0.05 -2.72%
Monatlich
-6.28%
Jährlich
-19.37%
Q1 Prognose
1.75




Aktuelle Verpflichtungen Veränderung Datum
Akebia Therapeutics USD 162.94M 29.56M 2025-12
Alaunos Therapeutics USD 921K 153K 2025-09
Avita Medical AUD 62.68M 77K 2025-12
Cspc Pharmaceutical CNY 10.11B 478.47M 2025-06
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Genomma Lab Internacional MXN 7.23B 254.33M 2025-12
Hypermarcas BRL 4.11B 849.68M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
IQVIA Holdings USD 8.34B 170M 2025-12
Jiangsu Hengrui CNY 7.85B 4.39B 2025-09
Kangmei Pharma CNY 5.81B 57.93M 2025-09
Moderna USD 1.99B 306M 2025-12
Organon & Co USD 2.68B 117M 2025-09
Revvity USD 1.33B 108.5M 2025-12
Sh Fosun Pharma CNY 35.09B 936.39M 2025-09
Tectonic Therapeutic USD 9.67M 293K 2025-12
Viatris USD 7.09B 269.8M 2025-12
Wuxi Apptec CNY 19.44B 1.08B 2025-09
Xeris Pharmaceuticals USD 109.57M 6.63M 2025-12
Zz Pientze Pharmaceu CNY 2.14B 1.06B 2025-09